Aslan touts data for competitor to Dupixent as it seeks new partners

Lei Lei Wu

News Reporter

Aslan Pharmaceuticals said Thursday morning that its experimental drug for eczema, or atopic dermatitis, helped more patients achieve nearly clear or clear skin compared to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Aslan touts data for competitor to Dupixent as it seeks new partners

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

FTC to sue major PBMs over insulin rebates, claiming they inflated patient cost

Biotech VC firm outlines plans for $100M fund

Novo says its CB1 drug helped shed weight, but efficacy and safety questions remain

Why did Eli Lilly ask a patient on a compounded GLP-1 drug for their medical information?

FDA OKs the first-ever self-administered vaccine, for flu

Breaking down silos with a new quantitative approach to drug development

Aslan touts da­ta for com­peti­tor to Dupix­ent as it seeks new part­ners

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Aslan touts data for competitor to Dupixent as it seeks new partners